Education
About Us
Working with TipRanks
Follow Us
Mereo Biopharma (MREO)
NASDAQ:MREO
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 10.00M | $ 0.00 | $ 49.21M | $ 0.00 |
| Gross Profit | $ 0.00 | $ 7.43M | $ 257.44K | $ 25.04M | $ -2.05M |
| Operating Income | $ -47.36M | $ -28.42M | $ -53.67M | - | $ -48.18M |
| EBITDA | $ -40.80M | $ -26.06M | $ -39.98M | $ 25.49M | $ -203.41M |
| Net Income | $ -43.25M | $ -29.47M | $ -42.12M | $ 17.17M | $ -209.83M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 69.80M | $ 57.42M | $ 68.18M | $ 127.52M | $ 32.09M |
| Total Assets | $ 76.39M | $ 66.50M | $ 77.41M | $ 170.96M | $ 86.08M |
| Total Debt | $ 6.43M | $ 5.95M | $ 15.37M | $ 22.66M | $ 24.53M |
| Net Debt | $ -63.37M | $ -51.47M | $ -52.81M | $ -104.08M | $ -6.82M |
| Total Liabilities | $ 15.42M | $ 15.96M | $ 26.01M | $ 51.95M | $ 106.55M |
| Stockholders' Equity | $ 60.97M | $ 50.54M | $ 51.40M | $ 119.01M | $ -20.47M |
| Cash Flow | |||||
| Free Cash Flow | $ -33.53M | $ -21.55M | $ -48.83M | $ -7.79M | $ -38.65M |
| Operating Cash Flow | $ -32.83M | $ -21.13M | $ -48.82M | $ -7.07M | $ -38.62M |
| Investing Cash Flow | $ -699.00K | $ -419.00K | $ 1.99M | $ -568.20K | $ 2.04M |
| Financing Cash Flow | $ 46.15M | $ 7.97M | $ 200.00K | $ 104.80M | $ 47.34M |